Document Detail

Safety and efficacy of enalapril in multivalvular heart disease with significant mitral stenosis--SCOPE-MS.
MedLine Citation:
PMID:  15793604     Owner:  NLM     Status:  MEDLINE    
Angiotensin-converting enzyme inhibitors (ACEI) are often used in preventing and treating heart failure due to regurgitant valve disease. The majority of patients with symptomatic rheumatic heart disease (RHD) have significant mitral stenosis (MS) and are denied ACEI therapy, because of the fear of hypotension in the presence of fixed obstruction. The authors assessed the safety and efficacy of ACEI in 109 consecutive patients with RHD and with significant mitral stenosis (mitral valve orifice, MVO < 1.5 cm2)and with NYHA class III or IV heart failure symptoms. Mean age was 33.1+/-12 years, systolic blood pressure (BP) was 111+/-10, and diastolic BP was 73+/-8 mm Hg. MS was significant in 100 patients with mitral regurgitation in 46, aortic regurgitation in 19, and pulmonary hypertension in 60 patients. After initial stabilization, enalapril 2.5 mg bid was started in hospital and titrated up to 10 mg bid over 2 weeks. NYHA status, Borg score, and 6-minute walk test were assessed at baseline, and at 1, 2, and 4 weeks. Seventy-nine of the 100 patients who completed the study had severe MS (MVO < 1.0 cm2). Enalapril was well tolerated by all study patients without hypotension or worsening of symptoms. NYHA class (3.2+/-0.5 baseline vs 2.3+/-0.5 at 4 weeks, p < 0.01) Borg Dyspnea Index (7.6+/-1.3 vs 5.6+/-1.3, p < 0.01), and 6-minute walk distance (226+/-106 vs 299+/-127 m, p < 0.01) improved significantly with enalapril. Patients with associated regurgitant lesions showed more improvement in exercise capacity (120+/-93 vs 39+/-56 m, p < 0.001). Enalapril was well tolerated in patients with RHD with moderate and severe MS. Irrespective of the valve pathology, enalapril improved functional status and exercise capacity with maximum benefit in patients with concomitant regurgitant valvular heart disease.
Anand Chockalingam; S Venkatesan; Smrita Dorairajan; V Chockalingam; T Subramaniam; V Jaganathan; S Elangovan; R Alagesan; G Gnanavelu; A S Arul
Related Documents :
7369664 - Have you checked all your breast implants?
1495314 - Carcinoid disease of the heart. surgical management of ten patients.
21122834 - Decreased concentrations of pigment epithelium-derived factor in peritoneal fluid of pa...
17184564 - The case for utilizing more strict quantitative doppler echocardiographic criterions fo...
20954284 - Etiology and long-term outcome of extrahepatic portal vein obstruction in children.
24821934 - Spontaneous intracranial hypotension with camptocormia.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Angiology     Volume:  56     ISSN:  0003-3197     ISO Abbreviation:  Angiology     Publication Date:    2005 Mar-Apr
Date Detail:
Created Date:  2005-03-28     Completed Date:  2005-05-24     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0203706     Medline TA:  Angiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  151-8     Citation Subset:  IM    
Department of Cardiology, Madras Medical College and Research Institute, Chennai, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angiotensin-Converting Enzyme Inhibitors / adverse effects,  therapeutic use*
Aortic Valve Insufficiency / drug therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Enalapril / adverse effects,  therapeutic use*
Exercise Test / drug effects
Follow-Up Studies
Heart Failure / drug therapy
Heart Valve Diseases / drug therapy*
Hemodynamics / drug effects
Hypertension, Pulmonary / drug therapy
Middle Aged
Mitral Valve Insufficiency / drug therapy
Mitral Valve Stenosis / drug therapy*
Prospective Studies
Rheumatic Heart Disease / drug therapy*
Treatment Outcome
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 75847-73-3/Enalapril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of direct stent implantation on QTc dispersion.
Next Document:  Clinical, echocardiographic, and hemodynamic characteristics of rheumatic mitral valve stenosis and ...